PQ
Paul T Quinlan (General Counsel) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $5.6M of ORKA (52,000 sh across 6 lots, as filed), executed Aug 14. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$7.1M
shares × price, as filed
Last traded
Oct 20
Filed Oct 20
Median ADV $139.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
ORKARecent filings
ORKASALE
Oruka Therapeutics, Inc.
View filing →
$562K7,100 sh across 2 lots
Exec Oct 20
Filed Oct 20 · 8:42 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $880K
9,399 sh across 3 lots
Exec Sep 21
Filed Sep 21 · 4:57 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $5.6M
52,000 sh across 6 lots
Exec Aug 14
Filed Aug 14 · 5:52 PM ET